Qualigen therapeutics presents data on its ras inhibitor program at the american association for cancer research: targeting ras conference

Data demonstrates potential anti-ras activity with qualigen's novel ras small molecule in both pancreatic and breast cancer in vivo models

QLGN Ratings Summary

QLGN Quant Ranking